Pachón-Ibáñez María Eugenia, Jiménez-Mejías Manuel Enrique, Pichardo Cristina, Llanos Ana Cristina, Pachón Jerónimo
Servicio de Enfermedades Infecciosas, Hospitales Universitarios Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain.
Antimicrob Agents Chemother. 2004 Nov;48(11):4479-81. doi: 10.1128/AAC.48.11.4479-4481.2004.
We determined the in vitro activities of tigecycline and imipenem against 49 isolates of Acinetobacter baumannii, including those resistant to imipenem. The MIC at which 50% of the isolates were inhibited (MIC(50)) and the MIC(90) for tigecycline and imipenem were 2 and 2 mg/liter and 32 and 128 mg/liter, respectively, with 92 and 20%, respectively, of the strains being susceptible. Tigecycline did not show bactericidal activity in the time-kill studies (n = 9 strains). Imipenem showed bactericidal activity against seven out of nine strains. These in vitro results show that tigecycline has good in vitro bacteriostatic activity against A. baumannii, including strains resistant to imipenem.
我们测定了替加环素和亚胺培南对49株鲍曼不动杆菌的体外活性,包括对亚胺培南耐药的菌株。替加环素和亚胺培南的50%抑菌浓度(MIC50)及90%抑菌浓度(MIC90)分别为2 mg/L和2 mg/L、32 mg/L和128 mg/L,菌株的敏感率分别为92%和20%。在时间杀菌试验中(n = 9株),替加环素未表现出杀菌活性。亚胺培南对9株中的7株表现出杀菌活性。这些体外试验结果表明,替加环素对鲍曼不动杆菌具有良好的体外抑菌活性,包括对亚胺培南耐药的菌株。